Summary
Not everyone will have been able to attend the Alzheimer’s Association International Conference in Toronto last week. The Alzheimer’s Association AAIC Press Office has been kind enough to provide a curated collection of associated publications, relating to the 2016 Alzheimer’s Association International Conference (AAIC®2016).
Reference
New reports from the Alzheimer’s Association International Conference® 2016. [Press Release]. [Toronto. Online]: Alzheimer’s Association, July 27th 2016.
The AAIC2016 Special Collection:
Note: Selected articles may be available freely; others will require a suitable Athens password, a journal subscription or payment for access.
Biomarkers and Diagnosis
Weiner, MW. Veitch, DP. Aisen, PS. [et al] (2015). 2014 Update of the Alzheimer’s Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. June 2015, 11(6), e1-e120. Full Text Link.
Aisen, PS. Petersen, RC. Donohue, M. [et al] (2015). Alzheimer’s Disease Neuroimaging Initiative 2 Clinical Core: progress and plans. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. July 2015, 11(7), 734-739. Full Text Link.
Beckett, LA. Donohue, MC. Wang, C. [et al] (2015). The Alzheimer’s Disease Neuroimaging Initiative phase 2: increasing the length, breadth, and depth of our understanding. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. July 2015, 11(7), 823-831. Full Text Link.
Jagust, WJ. Landau, SM. Koeppe, RA. [et al] (2015). The Alzheimer’s Disease Neuroimaging Initiative 2 PET Core: 2015. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. July 2015, 11(7), 757-771. Full Text Link.
Kang, JH. Korecka, M. Figurski, MJ. [et al] (2015). The Alzheimer’s Disease Neuroimaging Initiative 2 Biomarker Core: a review of progress and plans. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. July 2015, 11(7), 772-791. Full Text Link.
Toga, AW. [and] Crawford, KL. (2015). The Alzheimer’s Disease Neuroimaging Initiative informatics core: a decade in review. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. July 2015, 11(7), 832-839. Full Text Link.
Mukherjee, S. Walter, S. Kauwe, JSK. [et al] (2016). Genetically predicted body mass index and Alzheimer’s Disease-related phenotypes in three large samples: Mendelian randomization analyses. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. December 2015, 11(12), 1439-1451. Full Text Link.
Jones-Davis, DM. [and] Buckholtz, N. (2015). The impact of the Alzheimer’s Disease Neuroimaging Initiative 2: what role do public-private partnerships have in pushing the boundaries of clinical and basic science research on Alzheimer’s Disease? Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. July 2015, 11(7), 860-864. Full Text Link.
Weiner, MW. Veitch, DP. Aisen, PS. [et al] (2015). Impact of the Alzheimer’s Disease Neuroimaging Initiative, 2004 to 2014. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. July 2015, 11(7), 865-884. Full Text Link.
Hendrix, JA. Finger, B. Weiner, MW. [et al] (2015). The Worldwide Alzheimer’s Disease Neuroimaging Initiative: an update. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. July 2015, 11(7), 850-859. Full Text Link.
Epidemiology and Economics
Jones, RW. Romeo, R. Trigg, R. [et al] (2015). Dependence in Alzheimer’s Disease and service use costs, quality of life, and caregiver burden: the DADE study. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. March 2015, 11(3), 280-290. Full Text Link.
Leibson, CL. Long, KH. Ransom, JE. [et al] (2015). Direct medical costs and source of cost differences across the spectrum of cognitive decline: a population-based study. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. August 2015, 11(8), 917-932. Full Text Link.
Handels, RLH. Joore, MA. Tran-Duy, A. [et al] (2015). Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer’s Disease biomarkers for hypothetical disease-modifying treatment decision in mild cognitive impairment. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. August 2015, 11(8), 896-905. Full Text Link.
Ryan, J. Carrière, I. Carcaillon, L. [et al] (2014). Estrogen receptor polymorphisms and incident dementia: the prospective 3C study. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. January 2014, 10(1), 27-35. Full Text Link.
Chêne, G. Beiser, A. Au, R. [et al] (2015). Gender and incidence of dementia in the Framingham Heart Study from mid-adult life. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. March 2015, 11(3), 310-320. Full Text Link.
Lucca, U. Tettamanti, M. Logroscino, G. [et al] (2015). Prevalence of dementia in the oldest old: the Monzino 80-plus population based study. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. March 2015, 11(3), 258-270.e253. Full Text Link.
Radford, K. Mack, HA. Draper, B. [et al] (2015). Prevalence of dementia in urban and regional Aboriginal Australians. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. March 2015, 11(3), 271-279. Full Text Link.
Jia, J. Wang, F. Wei, C. [et al] (2014). The prevalence of dementia in urban and rural areas of China. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. January 2014, 10(1), 1-9. Full Text Link.
Prevention and Treatments
Vaudano, E. Vannieuwenhuyse, B. Van Der Geyten, S. [et al] (2015). Boosting translational research on Alzheimer’s Disease in Europe: the Innovative Medicine Initiative AD research platform. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. September 2015, 11(9), 1121-1122. Full Text Link.
Olsson, B. Legros, L. Guilhot, F. [et al] (2014). Imatinib treatment and Aβ42 in humans. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. May 2014, 10(5), S374-S380. Full Text Link.
Greig, NH. Tweedie, D. Rachmany, L. [et al] (2014). Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. January 2014, 10(1), S62-S75. Full Text Link.
Pelletier, A. Barul, C. Féart, C. [et al] (2015). Mediterranean diet and preserved brain structural connectivity in older subjects. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. September 2015, 11(9), 1023-1031. Full Text Link.
Morris, MC. Tangney, CC. Wang, Y. [et al] (2015). MIND diet associated with reduced incidence of Alzheimer’s Disease. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. September 2015, 11(9), 1007-1014. Full Text Link.
Morris, MC. Tangney, CC. Wang, Y. [et al] (2015). MIND diet slows cognitive decline with aging. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. September 2015, 11(9), 1015-1022. Full Text Link.
Talbot, K. [and] Wang, HY. (2014). The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer’s Disease. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. January 2014, 10(1), S12-S25. Full Text Link.
Schneider, LS. (2014). Rethinking the Food and Drug Administration’s 2013 guidance on developing drugs for early-stage Alzheimer’s Disease. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. February 2014, 10(2), 247-250. Full Text Link.
